Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
Status:
Completed
Trial end date:
2017-11-09
Target enrollment:
Participant gender:
Summary
This is an 8-week, randomized, placebo-controlled trial of modafinil in stable bipolar
disorder patients. Results will provide information on a promising treatment for
simultaneously treating both sleep and cognitive problems in stable bipolar patients. These
disabling symptoms persist despite stable mood and are strongly associated with functional
disability, making them important treatment targets that have not yet been adequately
addressed.